A Look Back at the Affordable Care Act
Drug Topics
DECEMBER 5, 2024
The Affordable Care Act was passed in 2010 to make health care and prescription medicine more accessible. Did it succeed?
Thu.Dec 05, 2024
255 
Combining Ruxolitinib and Supportive Anemia Care Enhances Myelofibrosis Treatment
Pharmacy Times
DECEMBER 5, 2024
The data support the use of supportive anemia care agents in combination with ruxolitinib (Jakafi; Incyte Corp).
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Phase 3 Trial to Evaluate Molnupiravir for Treatment of COVID-19 in High-Risk Adults
Drug Topics
DECEMBER 5, 2024
The MOVe-NOW study will assess the investigational oral antiviral using a different formulation than what is currently approved under an emergency use authorization.
Researchers Assess Shingles Vaccination Trends Among Older Adults With COPD
Pharmacy Times
DECEMBER 5, 2024
During a 15-year period, 1 in 5 older adults living with COPD received a shingles vaccine.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Primary care market will see major shifts by 2030 as payers, nontraditional providers gain ground
Fierce Healthcare
DECEMBER 5, 2024
Two years ago, Bain and Company forecasted ma | Nontraditional providers will account for about one-third of the primary care market in 2030, according to Bain and Company. Payer-owned primary care, population-focused models and advanced primary care providers are all poised for growth.
FDA Grants Orphan Drug Designation to Novel Gene Therapy for Fabry Disease
Pharmacy Times
DECEMBER 5, 2024
Fabry disease is a rare lysosomal disorder that causes excessive deposition of lipids in tissues.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Zenocutuzumab-zbco Granted Accelerated Approval for Patients With NSCLC, Pancreatic Ductal Adenocarcinoma
Pharmacy Times
DECEMBER 5, 2024
Zenocutuzumab-zbco is a bispecific antibody that targets and binds to HER2 and HER3.
AstraZeneca scores FDA nod for Imfinzi as first immunotherapy for limited-stage small cell lung cancer
Fierce Pharma
DECEMBER 5, 2024
AstraZeneca has picked off another label expansion for cancer blockbuster Imfinzi as the FDA has blessed it for limited-stage small cell lung cancer.
Financial Difficulty Persists Through Early Breast Cancer Survivorship for Some Patients
Pharmacy Times
DECEMBER 5, 2024
The authors suggest that targeted interventions to mitigate financial toxicity should be implemented to better support patients.
Still no clear motive in UnitedHealth CEO killing
pharmaphorum
DECEMBER 5, 2024
Investigations continue into the death of UnitedHealth chief executive Brian Thompson, who was shot and killed by an unknown assailant in New York
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
FDA Approves Durvalumab for Treatment of Adults Patients With LS-SCLC
Pharmacy Times
DECEMBER 5, 2024
The indication is for adults with limited-stage small cell lung cancer (LS-SCLC) whose disease has not progressed after platinum-based chemotherapy and radiation therapy.
Dark Chocolate Consumption Associated with Reduced Risk of Type 2 Diabetes
Drug Topics
DECEMBER 5, 2024
A recent study found that patients who consumed 5 or more servings a week of dark chocolate had a significantly lower rate of type 2 diabetes.
Surge in Hospital-Onset Respiratory Viral Infections Linked With Easing of Masking and Testing Policies
Pharmacy Times
DECEMBER 5, 2024
Reduced hospital masking and testing policies increased rates of hospital-onset respiratory infections, including RSV.
How This Pharmacist Achieved Dreams of Becoming an Independent Owner
Drug Topics
DECEMBER 5, 2024
TaQuina Warren, PharmD, owner of Focus Pharmacy in Smyrna, Delaware, explored the pharmacy profession from her perspective as an independent owner.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
5 Key Interviews, Sessions at the 2024 ASH Annual Meeting and Exposition
Pharmacy Times
DECEMBER 5, 2024
The American Society of Hematology (ASH) Annual Meeting and Exposition will include the latest news and clinical trial updates in the hematology field.
Ajovy Demonstrates Safety, Efficacy in Pediatric Migraines
Drug Topics
DECEMBER 5, 2024
The calcitonin gene-related peptide monoclonal antibody significantly reduced the number of monthly migraine days.
'Make the Healthy Choice the Easy Choice': Jerome Adams Advocates for Flu, COVID-19 Vaccinations Among Health Care Providers
Pharmacy Times
DECEMBER 5, 2024
Jerome Adams, former US surgeon general, discusses the importance of receiving recommended vaccines against influenza and COVID-19 for health care personnel.
Truth or Trend? Equipping Patients to Combat Misinformation
Drug Topics
DECEMBER 5, 2024
Pharmacists can monitor what health information circulates in mainstream media. But how can they rebut misinformation spread in private channels?
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Mounjaro cleared for NHS use, but patients may have to wait
pharmaphorum
DECEMBER 5, 2024
Many patients can expect a long wait for access to Eli Lilly's obesity shot Mounjaro, even though it has been recommended for routine NHS use by NICE
FDA Grants Breakthrough Therapy Designation to Sac-TMT for Previously Treated NSCLC
Pharmacy Times
DECEMBER 5, 2024
Sacituzumab tirumotecan (sac-TMT; Kelun Pharmaceutical, Merck) is currently being studied to treat non-small cell lung cancer (NSCLC) in the TroFuse-004 and TroFuse-009 trials.
Novartis bid to block generic Entresto in US suffers setback
pharmaphorum
DECEMBER 5, 2024
An appeals court in the US has declined to overturn an attempt by Novartis to block the launch of a generic of its heart failure blockbuster Entresto.
Anthem faces backlash from new anesthesia policy, reverses course in all states
Fierce Healthcare
DECEMBER 5, 2024
Merus grabs first-in-class US approval for NRG1 cancer drug
pharmaphorum
DECEMBER 5, 2024
Merus has its first approval for a commercial product, getting the go-ahead from the FDA for Bizengri, a first-in-class therapy for cancer
On an investment spree, Lilly will spend $3B to expand newly acquired injectables plant in Wisconsin
Fierce Pharma
DECEMBER 5, 2024
FDA clears AZ's Imfinzi for aggressive lung cancer
pharmaphorum
DECEMBER 5, 2024
AstraZeneca's Imfinzi becomes the first cancer immunotherapy to be FDA-approved for limited-stage small cell lung cancer (LS-SCLC)
Novartis' latest attempt to fend off MSN's Entresto generic falls short on appeal
Fierce Pharma
DECEMBER 5, 2024
Novartis’ latest effort to block a generic challenger to blockbuster heart med Entresto has come up short, this time in a federal appeals court. | The U.S. Court of Appeals for the Federal Circuit sided with a prior ruling that denied Novartis' motion seeking an injunction to prevent MSN's generic rival from launching.
STAT+: Pharmalittle: We’re reading about U.K. restricting Lilly’s obesity drug, pharma layoffs, and more
STAT
DECEMBER 5, 2024
Top of the morning to you, and a fine one it is, despite the dreary gray skies hovering over the Pharmalot campus. We are doing our best to maintain sunny spirits, though, because once again, we recall some helpful wisdom from the Morning Mayor, who taught us that “every new day should be unwrapped like a precious gift.” To celebrate the notion, we are brewing still more cups of stimulation and inviting you to join us.
AI is revolutionizing healthcare through automation while strengthening the traditional patient and provider care model
Fierce Healthcare
DECEMBER 5, 2024
Opinion: AI scribes are mostly rescuing doctors from themselves
STAT
DECEMBER 5, 2024
As we approach the end of 2024, First Opinion is publishing a series of essays on the state of AI in medicine and biopharma. Get a group of primary care physicians together, and there’s a pretty good chance they will start talking about the potential of AI scribes to reduce documentation burden and improve the clinician-patient office interaction.
Amgen rolls out $1B investment to build new drug substance plant in NC's biopharma hotbed
Fierce Pharma
DECEMBER 5, 2024
Amid a flurry of manufacturing activity in the state this year, Amgen is the latest drugmaker to bolster its production footprint in North Carolina. | Amgen is laying out $1 billion to build a second drug substance facility in Holly Springs, North Carolina. Together with Amgen’s existing facility in the town, the company’s investments in Holly Springs are slated to create a total of 370 new jobs.
Industry Voices—It's time for Congress to act on educating the healthcare workforce of the future
Fierce Healthcare
DECEMBER 5, 2024
Harnessing Marketing Networks in the Pharmaceutical Industry: Strategies for Success
Pharma Marketing Network
DECEMBER 5, 2024
Table of Contents Sr# Headings 1 Introduction: The Power of Marketing Networks 2 What Are Marketing Networks? 3 The Importance of Marketing Networks in Pharma 4 Building Healthcare Professional (HCP) Networks 5 Patient Advocacy Groups: A Trusted Connection 6 Digital Marketing Networks in Pharma 7 Branded Campaigns and Marketing Networks 8 Overcoming Challenges in Marketing Networks 9 The Role of Data in Strengthening Networks 10 Future Trends in Marketing Networks 11 Practical Tips for Pharma Ma
Let's personalize your content